ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Oncology Unit – How To Plan, Start It

February 10, 1978

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981